{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:13:35Z","timestamp":1785932015065,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City","award":["263\/2023 \/H\u0110-\u0110HYD"],"award-info":[{"award-number":["263\/2023 \/H\u0110-\u0110HYD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08325-3","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:53:42Z","timestamp":1776059622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BRAF and RAS mutations in Vietnamese patients with ameloblastoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Kien Ai","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Thi Kim","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuong Quoc","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram Bich","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao Thi Thu","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam Thi Thanh","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Cong Nhat","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Anh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7812-9141","authenticated-orcid":false,"given":"Tuyen Dac","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"3","key":"8325_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcms.2003.12.004","volume":"32","author":"T Tamme","year":"2004","unstructured":"Tamme T, Soots M, Kulla A, Karu K, Hanstein S, Sokk A, et al. Odontogenic tumours, a collaborative retrospective study of 75 cases covering more than 25 years from Estonia. J Craniomaxillofac Surg. 2004;32(3):161\u20135.","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"8325_CR2","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.4317\/medoral.19157","volume":"20","author":"A Sekerci","year":"2015","unstructured":"Sekerci A, Nazl\u0131m S, Etoz M, Den\u0131z K, Yasa Y. Odontogenic tumors: A collaborative study of 218 cases diagnosed over 12 years and comprehensive review of the literature. Med Oral Patol Oral Cir Bucal. 2015;20(1):e34\u20134.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"8","key":"8325_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.oraloncology.2008.11.001","volume":"45","author":"H Luo","year":"2009","unstructured":"Luo H, Li T. Odontogenic tumors: A study of 1309 cases in a Chinese population. Oral Oncol. 2009;45(8):706\u201311.","journal-title":"Oral Oncol"},{"issue":"9","key":"8325_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.joms.2006.05.019","volume":"64","author":"A Buchner","year":"2006","unstructured":"Buchner A, Merrell PW, Carpenter WM. Relative Frequency of Central Odontogenic Tumors: A Study of 1,088 Cases from Northern California and Comparison to Studies from Other Parts of the World. J Oral Maxillofac Surg. 2006;64(9):1343\u201352.","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"8325_CR5","first-page":"50","volume":"519","author":"TN Nguyen","year":"2022","unstructured":"Nguyen TN, Duong HH, Le VS, Tran DH. Study on the clinical, X-Ray and histopathologic features of the common odontogenic tumors. Vietnam Med J. 2022;519(10):50\u201367.","journal-title":"Vietnam Med J"},{"issue":"1","key":"8325_CR6","first-page":"679","volume":"7","author":"R Phulairi","year":"2016","unstructured":"Phulairi R, Rathore R, Thakkur R, Shah A. Extreme ameloblastoma. Oral Maxillofac Pathol J. 2016;7(1):679\u201382.","journal-title":"Oral Maxillofac Pathol J"},{"issue":"4","key":"8325_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13353-011-0057-x","volume":"52","author":"CS Pareek","year":"2011","unstructured":"Pareek CS, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing. J Appl Genet. 2011;52(4):413\u201335.","journal-title":"J Appl Genet"},{"key":"8325_CR8","doi-asserted-by":"crossref","unstructured":"Bilodeau EA, Seethala RR. Update on odontogenic tumors: Proceedings of the North American Head and Neck Pathology Society. Head Neck Pathol. 2019;13(3):457\u201365.","DOI":"10.1007\/s12105-019-01013-5"},{"key":"8325_CR9","doi-asserted-by":"publisher","first-page":"740788","DOI":"10.3389\/froh.2021.740788","volume":"2","author":"LM Guimaraes","year":"2021","unstructured":"Guimaraes LM, Coura BP, Gomez RS, Gomes CC. The molecular pathology of odontogenic tumors: Expanding the spectrum of MAPK pathway driven tumors. Front Oral Health. 2021;2:740788.","journal-title":"Front Oral Health"},{"issue":"5","key":"8325_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/path.4317","volume":"232","author":"KJ Kurppa","year":"2014","unstructured":"Kurppa KJ, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, et al. High frequency of BRAFV600E mutations in ameloblastoma. J Pathol. 2014;232(5):492\u20138.","journal-title":"J Pathol"},{"issue":"7","key":"8325_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ng.2986","volume":"46","author":"RT Sweeney","year":"2014","unstructured":"Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46(7):722\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"8325_CR12","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.oooo.2020.06.002","volume":"132","author":"P Lapthanasupkul","year":"2021","unstructured":"Lapthanasupkul P, Laosuk T, Ruangvejvorachai P, Aiittiwarapoj A, Kitkumthorn N. Frequency of BRAFV600E mutation in a group of Thai patients with ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;132(5):e180\u20135.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"8325_CR13","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1007\/s13277-015-3238-0","volume":"36","author":"MG Diniz","year":"2015","unstructured":"Diniz MG, Gomes CC, Guimar\u00e3es BV, Castro WH, Lacerda J, Cardoso S, et al. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 2015;36(7):5649\u201353.","journal-title":"Tumour Biol"},{"issue":"5","key":"8325_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jop.12851","volume":"48","author":"KY Oh","year":"2019","unstructured":"Oh KY, Cho SY, Yoon HJ, Lee JI, Ahn SG, Hong SD. High prevalence of BRAFV600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial\u2013mesenchymal transition. J Oral Pathol Med. 2019;48(5):413\u201320.","journal-title":"J Oral Pathol Med"},{"issue":"21","key":"8325_CR15","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1158\/1078-0432.CCR-14-1069","volume":"20","author":"NA Brown","year":"2014","unstructured":"Brown NA, Rolland D, McHugh JB, Weigelin H, Zhao L, Lim M, et al. Activating FGFR2\u2013RAS\u2013BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20(21):5517\u201326.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"8325_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijom.2006.11.003","volume":"36","author":"J Hong","year":"2007","unstructured":"Hong J, Yun P, Chung I, Suh J, Seo B, Lee J, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 2007;36(3):283\u20138.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"8325_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ijos.2012.8","volume":"4","author":"Y Li","year":"2012","unstructured":"Li Y, Han B, Li L. Prognostic and proliferative evaluation of ameloblastoma based on radiographic boundary. Int J Oral Sci. 2012;4(1):30\u20133.","journal-title":"Int J Oral Sci"},{"key":"8325_CR18","volume-title":"Diagnostic imaging of the jaw","author":"R Langlais","year":"1995","unstructured":"Langlais R, Langland O, Nortje C. Diagnostic imaging of the jaw. 1st ed. Baltimore: Willliams & Wilkins; 1995.","edition":"1"},{"issue":"4","key":"8325_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.surge.2020.06.009","volume":"19","author":"HA Shi","year":"2021","unstructured":"Shi HA, Ng C, Kwa CT, Sim Q, Ameloblastoma. A succinct review of the classification, genetic understanding and novel molecular targeted therapies. Surgeon. 2021;19(4):238\u201343.","journal-title":"Surgeon"},{"key":"8325_CR20","first-page":"19","volume":"7","author":"NA Brown","year":"2015","unstructured":"Brown NA, Betz BL, Ameloblastoma. A review of recent molecular pathogenetic discoveries. Biomark Cancer. 2015;7:19\u201324.","journal-title":"Biomark Cancer"},{"issue":"8","key":"8325_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/gcc.23040","volume":"61","author":"KY Oh","year":"2022","unstructured":"Oh KY, Cho SY, Yoon HJ, Lee JI, Ahn SG, Hong SD. BRAFV600E and previously unidentified KRASG12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type. Genes Chromosomes Cancer. 2022;61(8):481\u201390.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"8325_CR22","first-page":"146","volume":"20","author":"DT Vo","year":"2016","unstructured":"Vo DT, Le DL, Nguyen TH. Clinical, radiographic and histopathological features of ameloblastoma among Vietnamese. Ho Chi Minh City J Med. 2016;20(2):146\u201354.","journal-title":"Ho Chi Minh City J Med"},{"key":"8325_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42047-019-0041-z","volume":"2","author":"AM Cadavid","year":"2019","unstructured":"Cadavid AM, Araujo J, Coutinho C, Junior C, Bologna S, Lourenco S. Ameloblastoma: Current aspects of the new WHO classification in an analysis of 136 cases. Surg Exp Pathol. 2019;2:17.","journal-title":"Surg Exp Pathol"},{"issue":"2","key":"8325_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijom.2009.11.022","volume":"39","author":"ER Fregnani","year":"2010","unstructured":"Fregnani ER, Perez DEC, de Almeida OP, Kowalski LP, Soares FA, Alves F. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. Int J Oral Maxillofac Surg. 2010;39(2):145\u20139.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"8325_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tripleo.2004.08.031","volume":"99","author":"AL Ladeinde","year":"2005","unstructured":"Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Bamgbose BO, Arotiba GT, et al. Odontogenic tumors: A review of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(2):191\u20135.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"8325_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/odi.13031","volume":"26","author":"FN Hendra","year":"2020","unstructured":"Hendra FN, Koo E, Helder MN, de Visscher J, Leemans CR, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: A systematic review and meta-analysis. Oral Dis. 2020;26(1):12\u201321.","journal-title":"Oral Dis"},{"key":"8325_CR27","volume-title":"WHO classification of head and neck tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017.","edition":"4"},{"issue":"3","key":"8325_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.clinbiochem.2009.10.007","volume":"43","author":"YL Chang","year":"2010","unstructured":"Chang YL, Yeh KT, Hsu NC, Lin SC, Chang JG. Detection of N-, H-, and KRAS codons 12, 13, and 61 mutations with universal RAS primer multiplex PCR and N-, H-, and KRAS-specific primer extension. Clin Biochem. 2010;43(3):296\u2013301.","journal-title":"Clin Biochem"},{"key":"8325_CR29","volume-title":"The discovery and development of BRAF inhibitors","author":"P Harris","year":"2014","unstructured":"Harris P, Target BRAF. The discovery and development of BRAF inhibitors. 2nd ed. Amsterdam: Elsevier; 2014.","edition":"2"},{"issue":"2","key":"8325_CR30","first-page":"187","volume":"7","author":"J Cisowski","year":"2016","unstructured":"Cisowski J, Bergo MO. What makes oncogenes mutually exclusive? Small GTPases. 2016;7(2):187\u201392.","journal-title":"Small GTPases"},{"issue":"10","key":"8325_CR31","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/onc.2015.186","volume":"35","author":"J Cisowski","year":"2016","unstructured":"Cisowski J, Sayin VI, Liu M, Karlsson C, Bergo MO. Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF. Oncogene. 2016;35(10):1328\u201333.","journal-title":"Oncogene"},{"key":"8325_CR32","first-page":"108552","volume":"156","author":"BP Coura","year":"2025","unstructured":"Coura BP, Guimar\u00e3es LM, Gomez RS, Gomes CC. KRAS oncogenic mutations in benign tumors: adenomatoid odontogenic tumor as a model. Oral Oncol. 2025;156:108552.","journal-title":"Oral Oncol"},{"key":"8325_CR33","doi-asserted-by":"publisher","first-page":"740519","DOI":"10.3389\/froh.2021.740788","volume":"2","author":"LM Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es LM, Pires FR, Gomes CC, Gomez RS. The Molecular Pathology of odontogenic tumors: expanding the spectrum of MAPK pathway driven tumors. Front Oral Health. 2021;2:740519.","journal-title":"Front Oral Health"},{"issue":"4","key":"8325_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/pin.12899","volume":"70","author":"M Seki-Soda","year":"2020","unstructured":"Seki-Soda M, Sano T, Ito K, Yokoo S, Oyama T. An immunohistochemical and genetic study of BRAFV600E mutation in Japanese patients with ameloblastoma. Pathol Int. 2020;70(4):224\u201330.","journal-title":"Pathol Int"},{"issue":"1","key":"8325_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5306\/wjco.v11.i1.31","volume":"11","author":"R Gonzalez-Gonzalez","year":"2020","unstructured":"Gonzalez-Gonzalez R, Lopez-Verdin S, Carrasco J, Molina-Frencho N, Isiordia-Espinoza M, Carreon-Burciaga, et al. Current concepts in ameloblastoma-targeted therapies in BRAFV600E mutation: systematic review. World J Clin Oncol. 2020;11(1):31\u201342.","journal-title":"World J Clin Oncol"},{"issue":"1","key":"8325_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1590\/1981-863720170001000093070","volume":"65","author":"EC Maia","year":"2017","unstructured":"Maia EC, Sandrini FA. Management techniques of ameloblastoma: A literature review. RGO Rev Ga\u00facha Odontol. 2017;65(1):62\u20139.","journal-title":"RGO Rev Ga\u00facha Odontol"},{"issue":"3","key":"8325_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/his.13095","volume":"70","author":"ER Fregnani","year":"2017","unstructured":"Fregnani ER, Perez DEC, de Almeida OP, Fonseca FP, Soares FA, Castro-Junior G, et al. BRAFV600E expression correlates with ameloblastoma aggressiveness. Histopathology. 2017;70(3):473\u201384.","journal-title":"Histopathology"},{"issue":"14","key":"8325_CR38","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL. The frequency of Ras mutations in cancer. Cancer Res. 2020;80(14):2969\u201374.","journal-title":"Cancer Res"},{"issue":"8","key":"8325_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jclinpath-2021-207527","volume":"75","author":"R Bonacina","year":"2021","unstructured":"Bonacina R, Indini A, Massazza G, Rulli E, Gianatti A, Mandal\u00e0 M, et al. Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres. J Clin Pathol. 2021;75(8):555\u20139.","journal-title":"J Clin Pathol"},{"issue":"4","key":"8325_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/odi.13072","volume":"25","author":"J Kelppe","year":"2019","unstructured":"Kelppe J, Thor\u00e9n H, Ristim\u00e4ki A, Haglund C, Sorsa T, Hagstr\u00f6m J. BRAFV600E expression in ameloblastomas- A 36-patient cohort from Helsinki University Hospital. Oral Dis. 2019;25(4):1169\u201374.","journal-title":"Oral Dis"},{"issue":"1","key":"8325_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895293.2023.2270170","volume":"16","author":"C Ruixue","year":"2023","unstructured":"Ruixue C, Hexiang L, Yali H, Xiang L, Xu S, Jie W, et al. Clinicopathological relevance of BRAF and SMO mutations in Chinese patients with ameloblastoma. All Life. 2023;16(1):1\u20137.","journal-title":"All Life"},{"issue":"10","key":"8325_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1043-2760(02)00634-3","volume":"13","author":"P Driggers","year":"2002","unstructured":"Driggers P, Segars J. Estrogen activates Raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells. Part II: The role of growth factor signaling pathways in estrogen action. Trends Endocrinol Metab. 2002;13(10):422\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"25","key":"8325_CR43","doi-asserted-by":"publisher","first-page":"22558","DOI":"10.1074\/jbc.M202351200","volume":"277","author":"V Keshamouni","year":"2002","unstructured":"Keshamouni V, Mattingly R, Reddy K. Mechanism of 17\u03b2-estradiol-induced Erk1\/2 activation in breast cancer cells. J Biol Chem. 2002;277(25):22558\u201365.","journal-title":"J Biol Chem"},{"issue":"6","key":"8325_CR44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3803\/EnM.2022.1563","volume":"37","author":"M Kim","year":"2022","unstructured":"Kim M, Kim S, Ha S, Oh S, Kim D, Park J, et al. BRAFV600E mutation enhances estrogen-induced metastatic potential in thyroid cancer by regulating the expression of estrogen receptors. Endocrinol Metab (Seoul). 2022;37(6):879\u201390.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"11","key":"8325_CR45","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/genes11111342","volume":"11","author":"M \u015amiech","year":"2020","unstructured":"\u015amiech M, Leszczynski P, Kono H, Wardell C, Tanguchi H. Emerging BRAF mutations in cancer progression and their effects on estrogen-responsive genes. Genes (Basel). 2020;11(11):1342.","journal-title":"Genes (Basel)"},{"issue":"1","key":"8325_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0022034518798810","volume":"98","author":"K Heikinheimo","year":"2019","unstructured":"Heikinheimo K, Huhtala J, Thiel A, Heikinheimo H, Kurppa KJ, Heikinheimo H, et al. The mutational profile of unicystic ameloblastoma. J Dent Res. 2019;98(1):54\u201360.","journal-title":"J Dent Res"},{"issue":"3","key":"8325_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1259\/dmfr\/16752462","volume":"32","author":"T Koseki","year":"2003","unstructured":"Koseki T, Kakimoto N, Hashimoto K, Ariji Y, Tsuchimochi M, Toyama M, et al. Computed tomography of odontogenic myxoma. Dentomaxillofac Radiol. 2003;32(3):160\u20135.","journal-title":"Dentomaxillofac Radiol"},{"issue":"1","key":"8325_CR48","first-page":"e2668","volume":"27","author":"L Merbold","year":"2023","unstructured":"Merbold L, Smit C, Ker-Fox J, Uys A. The radiologic progression of ameloblastoma. SA J Radiol. 2023;27(1):e2668.","journal-title":"SA J Radiol"},{"issue":"4","key":"8325_CR49","first-page":"e468","volume":"24","author":"B Mariz","year":"2019","unstructured":"Mariz B, Andrade B, Agostini M, Almeida O, Romanach M Jr. Radiographic estimation of the growth rate of initially underdiagnosed ameloblastomas. Med Oral Patol Oral Cir Bucal. 2019;24(4):e468\u201372.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"2","key":"8325_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jop.13510","volume":"53","author":"C Smit","year":"2024","unstructured":"Smit C, Robinson L, Ker-Fox J, Fonsea F, Heerden W, Uys A. Clinicoradiologic features of ameloblastomas. J Oral Pathol Med. 2024;53(2):133\u201341.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"8325_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4103\/jomfp.JOMFP_174_17","volume":"22","author":"PK Shirsat","year":"2018","unstructured":"Shirsat PK, Bansal S, Prasad P, Desai RS. Low frequency of BRAFV600E immunoexpression in mandibular ameloblastomas: An institutional study. J Oral Maxillofac Pathol. 2018;22(3):353\u20139.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"1","key":"8325_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12105-021-01404-7","volume":"16","author":"M Vered","year":"2022","unstructured":"Vered M, Wright JM. Update from the 5th edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumors. Head Neck Pathol. 2022;16(1):63\u201375.","journal-title":"Head Neck Pathol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08325-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:54:33Z","timestamp":1781646873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08325-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8325"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08325-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7773170\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee in Biomedical Research, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam (Approval No. 272\/H\u0110\u0110\u0110-\u0110HYD, dated March 9, 2023). Written informed consent was obtained from all participants. Retrospective patients provided written consent during follow-up visits and prospective patients provided written consent during treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"992"}}